A Phase II/III Double Blind Randomized Trial of AZD2171 Versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer.
Phase of Trial: Phase II/III
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Cediranib (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Nov 2009 Final results published in JCO.
- 04 Aug 2009 Results presented at the 13th World Conference on Lung Cancer
- 02 Jun 2009 Hypertension data reported at ASCO 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History